FDA and CDC Call for Halt on Johnson & Johnson Vaccine Amid Cases of Clotting

The Food and Drug Administration and the Centers for Disease Control are calling for a halt on the Johnson & Johnson single-dose COVID-19 vaccine amid cases of clotting. It was reported that six recipients in the United States developed a rare disorder involving blood clots within about two weeks of vaccination.

All of the recipients who developed the clotting disorder were women between the ages of 18 and 48. One woman died and a second woman in Nebraska has been hospitalized in critical condition. This is out of the nearly 7 million people who have been vaccinated with the Johnson & Johnson vaccine.

Dr. Peter Marks, director of the Food and Drug Administration’s Center for Biologics Evaluation and Research, stated, “We are recommending a pause in the use of this vaccine out of an abundance of caution.”

Source: New York Times

Related posts

Leave a Comment